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The effect of polyphenolic bioactive substances, especially resveratrol (12.03 mg l–1), of an often consumed 
Hungarian red wine was investigated in a short term rat experiment. Male young Wistar albino rats were treated with 
high volumes of red wine (matching one bottle of wine/day for a 85 kg man) (N=5) and another alcoholic drink of 
the same alcohol concentration (N=5), corresponding to the circumstances of alcoholism, and 5 rats were in the 
control group. A total of 7 routine laboratory parameters were measured from the sera by kits.
The changes of redox homeostasis (H-donor activity, induced chemiluminescence, diene-conjugates, GSHPx) 
were studied in blood plasma and/or in liver homogenates by spectrophotometric and luminometric methods. 
Transmethylation property of the liver was measured by overpressured layer chromatography (OPLC) technique. It 
was proven with in vitro OPLC analytical study that resveratrol reacted with methyl groups, and resveratrol was 
demonstrated to infl uence transmethylation processes as well as redox homeostasis. Red wine compounds do not 
protect from the harmful effects of alcohol, and even by high doses of resveratrol, the liver further deteriorates and 
the negative effect of alcohol increases. It has been confi rmed that high doses of resveratrol do not provide protection 
against liver damage in those suffering from alcoholism.
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ADH: alcohol dehydrogenase; ALDH: aldehyde dehydrogenase; ALP: alkaline phosphatase; 
ALT: alanine transaminase; AST: aspartate transaminase; CHOL: cholesterol; CREAT: 
creatinine; CYP: cytochrome P450 isoenzymes; DPPH: 2,2-diphenyl-1-picryl-hydrazyl 
radical; GSH: glutathione; GSHPx: glutahione peroxidase; HCHO: formaldehyde; HDON: 
H-donor activity; MALDI-MS: matrix-assisted laser desorption/ionization - mass 
spectrometry; OPLC: overpressured layer chromatography; RLU: relative light unit; ROS: 
reactive oxidative substances; UA: uric acid; TG: triglyceride
The number of alcoholics and people suffering from diseases related to alcohol consumption 
increases in the world (HERBERT et al., 2017) despite that several studies have drawn the 
conclusion that biologically active antioxidant polyphenolic compounds, in particular 
fl avonoids and stilbenes, found in red wine, have favourable physiological effects. Especially 
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trans-resveratrol (resveratrol) reduces hazards of various cardiovascular diseases as well as 
cancer, diabetes, and so on (SZENDE et al., 2000; BRADAMANTE et al., 2004; CHIVA-BLANCH et 
al., 2013; MORENO-INDIAS et al., 2016; OH & SHAHIDI, 2018).
Resveratrol shows several biological effects, and the compound appears to have multiple 
molecular targets. For example, it inhibits the activity of various CYP enzymes and their 
expression through various nuclear factors, induces or inhibits Phase II enzymes, furthermore 
enhances fi brosis in a continuous gastric infusion rat model of ethanol exposure. Along with 
alcohol consumption, enhanced autophagy has also been observed (WU et al., 2012; MCGILL 
et al., 2015).
The in vivo antioxidant property of resveratrol is more likely to be attributable to its 
effect as a gene regulator. Resveratrol increases the expression of various antioxidant 
enzymes. Some of the gene-regulating effects of resveratrol are mediated by the histone/
protein deacetylase sirtuin-1 or by the nuclear factor-E2-related factor-2 (MCCUBREY et al., 
2017; XIA et al., 2017).
At dosage of 0.02 mg kg–1, resveratrol promoted antioxidant defence by preventing total 
and reduced GSH depletion caused by ischemia-reperfusion in rat liver, however, at high 
dosage (20 mg kg–1), it became prooxidant with an aggravation of liver injury, marked by 
aminotransferase release and histological picture, and associated with a depletion of total/
reduced GSH levels and a decrease of antioxidant enzyme activities (HASSAN-KHABBAR et al., 
2008).
An 8-week resveratrol administration (daily 3000 mg) has not benefi ted overweight/
obese patients with non-alcoholic fatty liver disease in an Australian clinical study. ALT and 
AST increased signifi cantly, but resveratrol was well-tolerated (CHACHAY et al., 2014).
Ethanol is converted into acetaldehyde through three major metabolic pathways. In the 
cytosol ALD, in the microsomes inducible CYP2E1, and in the peroxisomes catalase are 
involved in the transformation (LIEBER, 1997). During alcohol metabolism, primary and 
secondary ROS can be observed. Acetaldehyde accelerates GSH depletion and ROS mediated 
toxicity (WORRAL et al., 1993). CYP2EI is a major ROS generator, because ethanol reacts 
with H2O2, formed at detoxifi cation, meanwhile forming a 1-hydroxyethyl free radical 
(DUPONT et al., 1998).
GSH, which can inhibit ROS reactions, is rapidly eliminated in alcoholism. This is due 
to the lack of suffi cient methionine for the synthesis of cysteine, the main factor of GSH 
synthesis. Since the concentration of S-adenosylmethionine decreases in the cirrhotic liver 
considerably, the GSH regeneration slows down. In the absence of S-adenosylmethionine, 
many other vital metabolic pathways are also hindered. It is also proven that transfer of a 
methyl group happens via the formation of HCHO during the endogenous transmethylation 
processes. The abnormalities of the HCHO cycle may be potential risk factors (TYIHÁK et al., 
1998).
Resveratrol is a concentration-dependent HCHO capture molecule. In oxidizing 
environment, ROS can be formed in the reaction of resveratrol with HCHO. Quantum 
chemical calculations support the possibility of interaction between resveratrol and HCHO in 
biological systems, in which methoxy and formyl derivatives can be formed as presented in 
the study of MOLNÁR and co-workers (2008). TYIHÁK and co-workers (2011) analysed the 
reaction products of HCHO and resveratrol as well as HCHO and heart tissue by OPLC and 
MALDI-MS.
In this experiment, we were curious to know whether the polyphenol (1004 mg l–1), 
fl avonoid (quercetin 13.7 mg l–1, catechin 54.2 mg l–1, anthocyanins 73 mg l–1), and resveratrol 
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rich (12.03 mg l–1) red wine (alcohol concentration: 10.5%) consumption can modify the 
redox-balance involving GSHPx antioxidant enzyme activity and transmethylation processes.
1. Materials and methods
1.1. Materials
Egri cuvee red wine was purchased from Wine-cellars König (Hungary).
HCHO, DPPH, methanol, resveratrol, luminol, H2O2, microperoxidase, and bovine 
serum albumin were obtained from Sigma (USA). Routine laboratory kits were Reanal kits. 
All other reagents were of analytical grade, purchased from Reanal (Budapest).
1.2. Animal experiment
Male Wistar rats of 150–200 g were involved in the experiment. The animals were divided 
into three groups. Each group contained 5 rats. All animals were kept on normal rat chow. 
The controls were given tap water to drink. Alcohol-water solution of 10.5 v/v% or wine with 
the same alcohol concentration was added to the rats in alcohol treated groups. The rats were 
treated daily 8 ml kg–1 of body weight alcoholic solutions or wine for 10 days (which matches 
one bottle of wine/day for a 85 kg man). The animals were exsanguinated through the 
abdominal vein in deep pentobarbital narcosis (35 mg/bw kg i.p) on day 10, and blood was 
collected. Liver, sera, and plasma were prepared for the measurements. Measurements with 
kits were carried out and chemiluminescence as well as diene conjugates were detected 
promptly and consecutively, and all samples were stored at –20 ºC for other measurements. 
Permission Number: 770/004/04.
1.3. Methods
Blood was collected into tubes containing citrate for the plasma and native tubes for the sera 
(Greiner), and was centrifuged immediately at 4 ºC at 3000 r.p.m. for 10 min using standard 
method.
The liver was taken out, washed, and broken into small pieces, then washed with isotonic 
KCl solution. The bloodless liver pieces were homogenised with Potter-Elvehjem 
homogeniser at 0–4 ºC. The homogenates were standardised by protein content by the method 
of LOWRY and co-workers (1951) with bovine serum albumin.
AST, ALT, ALP, TG, CHOL, UA, and CREAT were carried out with Hitachi Modular 
and Advia 12 equipments using Reanal kits. HDON activity was determined by the method 
of HATANO and co-workers (1988). Chemiluminescense assay was adopted from BLÁZOVICS 
and SÁRDI (2018). Diene conjugates were determined after 20 hours at λ232 nm according to 
AOAC method (1984). GSHPx antioxidant enzyme activity was measured by RANSEL 
RS505 Randox kit.
Dimedone is a HCHO capture molecule, therefore, quantifi cation of formaldehyde is via 
formaldemethone. HCHO, as its dimedone adduct formaldemethone, has been detected with 
a fast and accurate OPLC by the methods of SÁRDI and TYIHÁK (1998). Molar ratio: resveratrol 
1, HCHO 5, dimedone solution 10 in methanol for 24 hours. The reaction mixture was used 
for chromatographic separations. The chromatographic separations were carried out on Silica 
gel 60 F254 precoated chromatoplates (Merck Co., Germany) using a chloroform-methylene 
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chloride mixture (35:65, V/V) for formaldemethone determination. Calibration curves were 
made by means of authentic substances at λ=265 nm for formaldemethone.
The liver samples were treated with dimedone solution (0.05% dimedone in methanol) 
for 24 hours. This suspension was centrifuged at 1500 g for 10 min at 4 ºC. The clear 
supernatants were used for chromatographic separations. The chromatographic separations 
were the same as described before.
1.4. Statistical analysis
For comparison of the results, Student’s t-test or Kruskal–Wallis test and ANOVA were done 
with Statistica 13 software. The signifi cance level was determined at P<0.05. Mean ± SD and 
c.v. % were calculated from the data.
2. Results and discussion
In rats that consumed red wine, signifi cantly higher ALP and UA values were measured. 
There were no changes in lipids, TG, and CHOL concentrations or in the CREAT of sera 
(Table 1). Red wine signifi cantly increased non-enzymatic antioxidant levels in the plasma, 
while GSHPx levels were signifi cantly reduced in both alcohol treated groups compared to 
the controls. Alcohol reduced and red wine increased free radical levels (RLU) in plasma 
compared to the controls.
Table 1. Changes of routine laboratory parameters during alcohol and red wine treatments
Groups
(mean±SD)
AST
(U l–1)
ALT
(U l–1)
ALP
(U l–1)
TG
(mmol l–1)
CHOL
(mmol l–1)
UA
(μmol l–1)
CREAT
(μmol l–1)
Control
(N=5)
63.16
±5.30
32.83a
±3.76
545a
±42
0.84
±0.40
1.65
±0.18
3.87a
±2.16
30.16
±1.47
Alcohol treated
(N=5)
55.20
±5.44
26.80b
±3.27
490b
±49
0.63
±0.20
1.46
±0.15
8.20b
±2.58
29.20
±1.78
Red wine treated
(N=5)
56.20
±7.98
30.60
±3.50
560c
±70
0.70
±0.17
1.50
±0.33
12.00b
±7.11
27.60
±1.81
Signifi cance P<0.05: a vs b, b vs c
The transmethylation abilities of livers were different among the groups. In both treated 
groups, liver HCHO concentrations (in formaldemethone form) were signifi cantly lowered 
compared to the control group. The strong ROS reactions (RLU) and the moderated activity 
of enzymatic defence led to formation of diene conjugates of lipids (Table 2), even though 
concentration of antioxidant molecules (HDON) in treated groups was high.
Figure 1 shows the changes in formaldemethone concentrations without and with 
resveratrol in an in vitro experiment. When the resveratrol-formaldehyde reaction product 
with dimedone in OPLC system was detected, the molar ratio was: resveratrol 1, HCHO 5, 
dimedon 10.
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Table 2. Changes of antioxidant profi le of plasma and liver homogenates during alcohol and red wine treatments
Groups
(mean±SD)
Plasma
HDON
(mmol l–1)
Plasma 
GSHPx
(U l–1)
Plasma
(RLU)
Diene- con-
jugates
(Abs.233/ml)
Liver
HDON
(mmol l–1)
Liver
(RLU)
HCHO
(μg g–1)
Control
(N=5)
1.067a
±0.21
3955a
±500
1.274×106a
c.v.<0.5%
0.191a
±0.057
46.84
±8.91
1.983×106a
c.v.<0.5%
7.29a
±1.29
Alcohol 
treated
(N=5)
1.004
±0.23
4263b
±476
7.26×105b
c.v.<0.5%
0.239
±0.053
48.55
±7.80
2.388×106 b
c.v.<0.5%
5.72b
±1.04
Red wine 
treated
(N=5)
1.215b,c
±0.11
3585c
±458
1 .811×106b,c
c.v.<0.5%
0.308b
±0.053
52.21
±5.07
3.082×106b,c
c.v.<0.5%
5.22b
±0.41
Signifi cance P<0.05: a vs b, b vs c
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Fig. 1. Detection of resveratrol-formaldehyde reaction product with dimedone system
(Molar ration: resveratrol 1: HCHO 5: dimedon 10)
The HCHO concentration in formaldemethone without resveratrol was 28.2 μg g–1 ± c.v. 
5% and with resveratrol was 21.6 μg g–1 ± c.v. 5%.
Since it is known that the concentration of S-adenosylmethionine, the main methylation 
agent in the body, is reduced in alcoholism, the question is, whether the bioactive components 
(fl avonoids and resveratrol) of red wine can contribute to a moderation in alcoholic liver 
diseases? According to the literature, the answer is linked to resveratrol (TYIHÁK et al., 1998; 
2011). Egri cuvée contains a high concentration of resveratrol, almost 1.5–3 times higher 
than the commercially available red wines (VRHOVSEK et al., 1995; SOUTO et al., 2001).
It was verifi ed in an in vitro dimedone reaction system that resveratrol can react with 
bound HCHO, also confi rmed by MOLNÁR and co-workers (2008).
The equivalent alcohol content of red wine and alcoholic drink did not damage the liver 
functions signifi cantly in this short term, 10-day-long experiment, which is clearly apparent 
from the routine laboratory results, but the redox parameters indicate that red wine surprisingly 
favours lipid peroxidation processes.
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Among plasma redox parameters, H-donor activity indicated that red wine polyphenols 
could be absorbed in rats. Non-specifi c antioxidant protection diminished the activity of 
GSHPx signifi cantly. The plasma inducible ROS level increased due to the consumption of 
red wine. Interestingly, the alcohol diminished its level, which could be due to the fact that 
the antioxidant compounds of the rat chow could be absorbed better by the alcohol, while the 
excess antioxidant compounds of wine could already modify the redox equilibrium negatively.
The effectiveness of red wine-derived antioxidants could be detected by the moderately 
higher H-donor activity in the liver. At the same time, lipid peroxidation processes were 
intensifi ed. Higher diene conjugation concentration and signifi cant inducible 
chemiluminescence intensity indicated ROS formation in the livers of both treated groups. 
Meanwhile, a signifi cant decrease was observed in methylation capacity in both treated 
groups.
To prove that resveratrol was the cause of moderated transmethylation ability during red 
wine treatment, an in vitro experiment was conducted.
The primary cause was found to be the decreased concentration of methyl groups 
accompanying the metabolism of alcohol, and the reaction of resveratrol with HCHO was the 
next. The HCHO molecule is in connection with the redox homeostasis, playing an important 
role with ROS in the biological system. According to our in vitro and in vivo data, it is 
assumed that resveratrol HCHO reaction might affect the methylation level, causing changes 
in enzyme activity of glutathione peroxidase via lower glutathione concentration through the 
formaldehyde cycle (TYIHÁK et al., 1998).
3. Conclusions
Damage caused by the alcohol content of the wines cannot be avoided by other bioactive 
compounds of the wines in case of alcoholism. Our results confi rm that resveratrol is a Janus 
faced bioactive molecule.
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